Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Anna Sarah Messmer, MD, Yok-Ai Que, MD, PhD, Christoph Schankin, MD, PhD, Yara Banz, MD, PhD, Ulrike Bacher, MD, Urban Novak, MD, Thomas Pabst, MD
Format:	article
Langue:	EN
Publié:	Wolters Kluwer 2021
Sujets:	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
Accès en ligne:	https://doaj.org/article/5d783eb858b94f3db43a5113857ec6df
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:5d783eb858b94f3db43a5113857ec6df
record_format	dspace
spelling	oai:doaj.org-article:5d783eb858b94f3db43a5113857ec6df2021-11-25T07:56:43ZNovel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland2639-802810.1097/CCE.0000000000000552https://doaj.org/article/5d783eb858b94f3db43a5113857ec6df2021-10-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000552https://doaj.org/toc/2639-8028Anna Sarah Messmer, MDYok-Ai Que, MD, PhDChristoph Schankin, MD, PhDYara Banz, MD, PhDUlrike Bacher, MDUrban Novak, MDThomas Pabst, MDWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 10, p e0552 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
spellingShingle	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Anna Sarah Messmer, MD Yok-Ai Que, MD, PhD Christoph Schankin, MD, PhD Yara Banz, MD, PhD Ulrike Bacher, MD Urban Novak, MD Thomas Pabst, MD Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
format	article
author	Anna Sarah Messmer, MD Yok-Ai Que, MD, PhD Christoph Schankin, MD, PhD Yara Banz, MD, PhD Ulrike Bacher, MD Urban Novak, MD Thomas Pabst, MD
author_facet	Anna Sarah Messmer, MD Yok-Ai Que, MD, PhD Christoph Schankin, MD, PhD Yara Banz, MD, PhD Ulrike Bacher, MD Urban Novak, MD Thomas Pabst, MD
author_sort	Anna Sarah Messmer, MD
title	Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
title_short	Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
title_full	Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
title_fullStr	Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
title_full_unstemmed	Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
title_sort	novel adaptive t-cell oncological treatments lead to new challenges for medical emergency teams: a 2-year experience from a tertiary-care hospital in switzerland
publisher	Wolters Kluwer
publishDate	2021
url	https://doaj.org/article/5d783eb858b94f3db43a5113857ec6df
work_keys_str_mv	AT annasarahmessmermd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT yokaiquemdphd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT christophschankinmdphd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT yarabanzmdphd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT ulrikebachermd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT urbannovakmd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland AT thomaspabstmd noveladaptivetcelloncologicaltreatmentsleadtonewchallengesformedicalemergencyteamsa2yearexperiencefromatertiarycarehospitalinswitzerland
_version_	1718413619977256960

Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland

Documents similaires